Start for free
Start for free
Monashee Investment Management logo

Monashee Investment Management

North America, Massachusetts, United States, Boston

Description

Monashee Investment Management is a hedge fund.

Investor Profile

Monashee Investment Management has made 29 investments, with 0 in the past 12 months and 3% as lead.

Stage Focus

  • Post Ipo Equity (41%)
  • Series C (24%)
  • Series B (17%)
  • Series A (7%)
  • Series D (7%)
  • Convertible Note (3%)

Country Focus

  • United States (86%)
  • United Kingdom (10%)
  • Switzerland (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Medical Device
  • Life Science
  • Pharmaceutical
  • Genetics
  • Health Diagnostics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Monashee Investment Management frequently co-invest with?

EcoR1 Capital
EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 4
OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 5
Surveyor Capital
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 4
Farallon Capital Management
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 4
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 5
Deerfield
Deerfield
North America, New York, United States, New York
Co-Investments: 4
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 4
Janus Henderson Investors
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 4
Invus
Invus
North America, New York, United States, New York
Co-Investments: 5
Fidelity
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 5

Which angels does Monashee Investment Management often collaborate with?

SB
Sahin Boydas
North America, California, United States
Shared Deals: 1
JD
Jeff Dean
North America, California, United States, Palo Alto
Shared Deals: 1
DB
Dmitry Balyasny
North America, Illinois, United States, Chicago
Shared Deals: 1
JG
Jude Gomila
North America, California, United States, San Francisco
Shared Deals: 1
JT
Jaan Tallinn
Europe, Harjumaa, Estonia, Tallinn
Shared Deals: 1
JR
Jesse Robbins
North America, California, United States, San Francisco
Shared Deals: 1
LA
Laurence A. Tosi
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Monashee Investment Management?

Pepgen

Oxford, Oxfordshire, United Kingdom

PepGen is empowering nucleic acid therapeutics to go the distance.

BiotechnologyClinical TrialsMedical
Post Ipo EquityFeb 7, 2024
Amount Raised: $80,100,000
Compass Therapeutics, Inc.

Boston, Massachusetts, United States

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

BiopharmaBiotechnologyTherapeutics
Post Ipo EquityNov 2, 2022
Amount Raised: $80,000,000
Gossamer Bio

San Diego, California, United States

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityJul 13, 2022
Amount Raised: $120,000,000
MoonLake Immunotherapeutics

Zug, Zug, Switzerland

MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.

Biotechnology
Post Ipo EquityApr 6, 2022
Amount Raised: $115,000,000
Scipher Medicine

Waltham, Massachusetts, United States

Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.

Alternative MedicineBiotechnologyGeneticsHealth CareHealth Diagnostics
Series DFeb 24, 2022
Amount Raised: $110,000,000
AN2 Therapeutics

Menlo Park, California, United States

AN2 Therapeutics focuses on modern biomedical and drug development expertise to provide transformational medicines.

BiotechnologyHealth CarePharmaceutical
Series BJan 7, 2022
Amount Raised: $80,000,000
Korro Bio

Cambridge, Massachusetts, United States

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

BiotechnologyHealth CarePharmaceutical
Series BJan 5, 2022
Amount Raised: $116,000,000
Pardes Biosciences

Carlsbad, California, United States

Pardes Biosciences is a biotechnology company that develops and commercializes direct-acting antivirals for the treatment of coronavirus.

BiotechnologyLife Science
Post Ipo EquityDec 27, 2021
Amount Raised: $75,000,000
Quell Therapeutics

London, England, United Kingdom

Quell Therapeutics is a cell therapy company

AssociationBiotechnologyEducationHealth Care
Series BNov 29, 2021
Amount Raised: $156,000,000
HotSpot Therapeutics

Boston, Massachusetts, United States

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics
Series CNov 29, 2021
Amount Raised: $100,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator